Theratechnologies Inc. (THTX)
Sep 25, 2025 - THTX was delisted (reason: acquired by Future Pak)
3.420
+0.030 (0.88%)
Inactive · Last trade price
on Sep 26, 2025
Theratechnologies Revenue
Theratechnologies had revenue of $17.73M in the quarter ending May 31, 2025, a decrease of -19.48%. This brings the company's revenue in the last twelve months to $84.38M, up 2.19% year-over-year. In the fiscal year ending November 30, 2024, Theratechnologies had annual revenue of $85.87M with 5.02% growth.
Revenue (ttm)
$84.38M
Revenue Growth
+2.19%
P/S Ratio
1.75
Revenue / Employee
$819,204
Employees
103
Market Cap
147.41M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2024 | 85.87M | 4.10M | 5.02% |
Nov 30, 2023 | 81.76M | 1.71M | 2.13% |
Nov 30, 2022 | 80.06M | 10.23M | 14.66% |
Nov 30, 2021 | 69.82M | 3.77M | 5.71% |
Nov 30, 2020 | 66.05M | 2.84M | 4.49% |
Nov 30, 2019 | Pro | Pro | Pro |
Nov 30, 2018 | Pro | Pro | Pro |
Nov 30, 2017 | Pro | Pro | Pro |
Nov 30, 2016 | Pro | Pro | Pro |
Nov 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTHTX News
- 2 days ago - Theratechnologies Announces Completion of Acquisition by Future Pak - GlobeNewsWire
- 11 days ago - Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak - GlobeNewsWire
- 15 days ago - Theratechnologies Inc. (TH:CA) Special Meeting Of Shareholders Of Theratechnologies Call (Transcript) - Seeking Alpha
- 15 days ago - Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak - GlobeNewsWire
- 22 days ago - Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy - GlobeNewsWire
- 25 days ago - Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak - GlobeNewsWire
- 5 weeks ago - Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak - GlobeNewsWire
- 2 months ago - Theratechnologies Reports Financial Results for the Second Quarter 2025 - GlobeNewsWire